| Product |
CAS |
Molecular formula |
More |
| Desloratadine impurity c |
117811-20-8 |
C19H17ClN2 |
More |
| Loratadine ep impurity f |
125743-80-8 |
C22H23ClN2O2 |
More |
| 3-Hydroxy desloratadine hcl |
19410-08-1 |
|
More |
| Losartan impurity k |
1159977-26-0 |
C21H20Cl2N6 |
More |
| Losartan related compound a |
1247750-67-0 |
|
More |
| Des(2-methylbutyrate) lovastatin hydroxy acid sodium salt |
75225-51-3 |
C24H38O6•H3N |
More |
| Lercanidipine impurity b |
1119226-97-9 |
|
More |
| Levonorgestrel impurity q |
1038-28-4 |
C20H30O2 |
More |
| Levonorgestrel impurity t |
799-43-9 |
C22H30O2 |
More |
| 10-Beta-hydroxy levonorgestrel |
21508-50-9 |
C21H28O3 |
More |
| Levonorgestrel impurity n |
4222-96-2 |
C19H26O2 |
More |
| Levofloxacin n-oxide |
117678-38-3 |
C18H20FN3O5 |
More |
| Levofloxacin tetrafluoro impurity 2 |
103995-33-1 |
|
More |
| (R)-o-acetyl-lacosamide |
1318777-54-6 |
|
More |
| Tafluprost acid |
209860-88-8 |
C22H28F2O5 |
More |
| (S)-(e)-luliconazole isomer |
256424-63-2 |
|
More |
| Laropiprant-d4 |
1132664-22-2 |
|
More |
| Levosimendan impurity (2-[2-[4-(2-azidotetrahydro-3-methyl-5-oxo-2-fur |
252638-01-0 |
C14H11N7O2 |
More |
| Lipoic acid related compound |
916746-61-7 |
|
More |
| Loxoprofen ring-opening impurity |
1091621-61-2 |
|
More |
